affymetrix inc (AFFX) Key Developments
Affymetrix Inc. Appoints Board of Directors
May 15 15
On May 13, 2015, the Board of Directors of Affymetrix elected Riccardo Pigliucci to the Board of Directors of the company and appointed Mr. Pigliucci a member of its Compensation Committee. Mr. Pigliucci will participate in the company's compensation program for non-employee directors, as amended, including an annual retainer of $45,000, and an initial award of options to purchase 30,000 shares of the company's common stock, which will vest and become exercisable in equal installments on each of the first three anniversaries of the date of grant, subject to Mr. Pigliucci's continued service on the Board through each vesting date. Mr. Pigliucci has served as the Managing Partner of Aldwych Associates, LLP since 2006. Prior to joining Aldwych Associates, LLP and since 2005, he served as an independent consultant. Mr. Pigliucci was Chairman and Chief Executive Officer of Discovery Partners International Inc. from 1998 until 2005. Mr. Pigliucci currently serves as Chairman of the Board of Directors of Medaphor PLC. The Board of Directors values Mr. Pigliucci's experience in the life sciences and healthcare equipment industry. The annual meeting of the stockholders of the company was held on May 13, 2015. At the Meeting, the stockholders elected Frank Witney as nominee as director.
Affymetrix Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-14-2015 09:20 AM
May 14 15
Affymetrix Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-14-2015 09:20 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Andy Last, Chief Operating Officer.
Affymetrix Mulls Acquisitions
May 14 15
Affymetrix Inc. (NasdaqGS:AFFX) is seeking acquisitions. Andy Last, Executive Vice President, said, "Strengthening our balance sheet to stage us for what we are now in, which we are calling our Phase 3 of our roadmap beginning of this year, where we wish to, obviously, deliver sustainable, profitable growth, and then expand in our market segments of choice and increase our ability to make small tuck-ins and acquisitions."
Affymetrix Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015
Apr 29 15
Affymetrix Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenue of $88,717,000 compared to $82,971,000 a year ago. Income from operations was $7,285,000 compared to loss from operations of $8,742,000 a year ago. Income before income taxes was $5,129,000 compared to loss before income taxes of $10,202,000 a year ago. Net income was $4,386,000 compared to net loss of $10,474,000 a year ago. Basic and diluted net income per share was $0.06 compared to basic and diluted net loss per share of $0.14 a year ago. Basic and diluted Non-GAAP net income was $7,884,000 compared to $1,904,000 a year ago. Basic and diluted Non-GAAP net income per share was $0.10 compared to $0.03 a year ago. EBITDA was $12,145,000 compared to $3,135,000 a year ago. Adjusted EBITDA was $17,132,000 compared to $12,916,000 a year ago. The company generated cash flow of approximately $1.3 million from operating activities.
Affymetrix Inc. Presents at UBS Global Healthcare Conference, May-19-2015 08:30 AM
Apr 21 15
Affymetrix Inc. Presents at UBS Global Healthcare Conference, May-19-2015 08:30 AM. Venue: Sheraton New York Times Square Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Franklin R. Witney, Chief Executive Officer, President and Director, Gavin H. J. Wood, Chief Financial Officer, Principal Accounting Officer and Executive Vice President.